个人简介

2010-2014: PhD in Bio-inorganic Chemistry at the University of Leeds (Dr Patrick McGowan) 2006-2010: MChem (1st Class Hons) at the University of Leeds 2014-2015: EPSRC Postdoctoral Research Associate at the University of Edinburgh (Professor Polly Arnold) 2016-present: Lecturer of Bioinorganic Chemistry at the University of Bradford

研究领域

Interested in the design and synthesis of inorganic molecules for their uses in anti-cancer research. In particular the synthesis of redox active metal complexes for targeting hypoxia cells.

Inorganic synthesis, Transition metal chemistry, Organometallic chemistry, Medicinal chemistry, Coordination chemistry, Redox active metals, Anti-cancer drugs, Hypoxia-targeting drugs, Apoptosis studies, Enzyme inhibition

近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

R. M. Lord,* S. J. Allison, K. Rafferty, L. Ghandhi, C. M. Pask and P. C. McGowan,* 'Cytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosis,' Dalton Trans, 2016, in press 10.1039/C6DT01464J R. M. Lord,* S. M. Lord, C. M. Pask and P. C. McGowan,* 'Structural studies of titanium(IV) picolinamide alkoxide and oxide derivatives,' Polyhedron, 2016, in press, 10.1039/C6DT01464J (Invited article for a special 80th birthday issue for Professor Malcolm Green) S. J. Lucas, R. M. Lord, A. M. Basri, S. J. Allison, R. M. Phillips, A. John Blacker and P. C. Mcgowan,* 'Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes,' Dalton Trans, 2016, 45, 6812-6815 (HOT Dalton Trans. article July 2016) R. M. Lord, A. J. Hebden, C. M. Pask, I. R. Henderson, S. J. Allison, S. L. Shepherd, R. M. Phillips and P. C. McGowan,* 'Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis,' J. Med. Chem., 2015, 58 (12), 4940–4953 A. Santoro,* R. M. Lord, J. J. Loughrey, P. C. McGowan, M. A. Halcrow,* A. F. Henwood, C. Thomson and E. Zysman-Coleman,* 'One-Pot Synthesis of Highly Emissive Dipyridinium Dihydrohelicenes,' Chem. Eur. J, 2015, 21 (19), 7035-7038 P. L. Arnold,* A. -F. Pecharman, R. M. Lord, G. M. Jones, E. Hollis, G. S. Nichol, L. Maron, J. Fang, T. Davin and J. B. Love*, 'Control of Oxo-Group Functionalization and Reduction of the Uranyl Ion,' Inorg. Chem., 2015, 54 (7), 3702-3710 A.Rodriguez-Barzano, R. M. Lord, A. M. Basri, R. M. Phillips, A. John Blacker and P. C. McGowan,* 'Synthesis and anticancer activity evaluation of η5-C5(CH3)4R ruthenium complexes bearing chelating diphosphine ligands', Dalton Trans., 2015, 44, 3265-3270 R. M. Lord, J. J. Mannion, A. J. Hebden, B. D. Crossley, A. E. Nako, M. W. McMullon, F. D. Janeway, R. M. Phillips and P. C. McGowan,* ‘Mechanistic and Cytotoxicity studies of Group IV b-Diketonate Complexes‘, ChemMedChem, 2014, 9, 1136-1139 (Special issue: Metals in Medicine – April 2014) 2. V. Brabec,* S. E. Howson, R. A. Kaner, R. M. Lord, J. Malina, R. M. Phillips, Q. M. A. Abdallah, P. C. McGowan, A. Rodger and P. Scott,* ‘Metallohelices with Activity Against Cisplatin-Resistant Cancer Cells; does the mechanism involve DNA binding?’, Chem. Sci, 2013, 4, 4407-4416 (HOT Chemical Science article - September 2013) S. J. Lucas, R. M. Lord, R. L. Wilson, R. M. Phillips, V. Sridharan and P. C. McGowan,* ‘Synthesis of Iridium and Ruthenium Arene Complexes as (N,N), (N,O) and (O,O) Coordinating Bidentate Ligands as Potential Anti-Cancer Agents’, Dalton Trans., 2012, 41, 13800-13802 (Top 10 most accessed articles - September 2012)